Effect of pemetrexed on brain metastases from nonsmall cell lung cancer with wild-type and unknown EGFR status

We aimed to evaluate the effectiveness of pemetrexed-based chemotherapy in wild-type nonsmall-cell lung cancer (NSCLC) patients with brain metastases (BM). Brain metastases are a common cause of mortality in NSCLC patients. For epidermal growth factor receptor (EGFR) wild-type patients, therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiaoqing, Fan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370158/
https://www.ncbi.nlm.nih.gov/pubmed/30653134
http://dx.doi.org/10.1097/MD.0000000000014110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370158/
https://www.ncbi.nlm.nih.gov/pubmed/30653134
http://dx.doi.org/10.1097/MD.0000000000014110

Ejemplares similares